Ultrasonographic Evaluation of Fetal Adrenal Gland in Cases of Threatened Preterm Labor
1 other identifier
observational
30
1 country
1
Brief Summary
Preterm birth continues to be a major public health problem with lasting family and societal repercussions. Despite tremendous research effort, prevention strategies have failed, and the prevalence of preterm birth in the United States reached 12.3% in 2003. Prematurity causes 70% of fetal/neonatal deaths. 11.4% of births are at \< 37 weeks' gestation. The rate of prematurity increases dramatically with the number of fetuses - singletons 10%; twins 54.9%; and triplets 93.6%
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 13, 2017
CompletedFirst Posted
Study publicly available on registry
August 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2018
CompletedJune 27, 2018
June 1, 2018
1 year
August 13, 2017
June 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
the volume of adrenal gland
measurement by three dimensional ultrasound
5 minutes
Study Arms (1)
threatened preterm labor
women presented to the reception unit from 28-37 weeks by regular contractions and opened cervix
Interventions
evaluation of the suprarenal glands
Eligibility Criteria
women with threatened preterm labor
You may qualify if:
- singleton fetus less than 37 weeks of gestation
- women diagnosed to having Threatened preterm labor.
- presence of uterine contraction (at least 4 in 20 min or 8 in 60 min )
- cervical effacement \<80 %
- cervical dilatation \<1 cm
You may not qualify if:
- suspected fetal growth restriction,
- maternal medical complications,
- presence of fetal heart rate abnormalities at enrollment.
- Preterm Premature rupture of membranes
- Placenta previa
- Lower urinary tract infection or genital infection
- Fetal congenital anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut Faculty of Medicine
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 13, 2017
First Posted
August 16, 2017
Study Start
March 1, 2017
Primary Completion
March 15, 2018
Study Completion
April 18, 2018
Last Updated
June 27, 2018
Record last verified: 2018-06